the patients were divided into 5 groups receiving equally cefotaxime 3 x 2 g , lamoxactam 3 x 2 g , cefmenoxime 3 x 1 g , mezlocillin 3 x 5 g an piperacillin 3 x 4 g .
C0007554
cefotaxime
C0007549
cefmenoxime